Abstract
Introduction
Megakaryocytes (MKs) shed platelets by forming cytoplasmic extensions called proplatelets. 1 At the end of maturation, MKs migrate towards marrow sinusoids and either entirely transmigrate before forming platelets, 2 or protrude their proplatelets through the vascular endothelium. 3 Ectopic localisation of this process within the bone marrow environment would severely compromise efficient platelet production because platelets have low capacities for chemotaxis and transmigration, and therefore need to be directly released into the bloodstream. For this reason, efficient platelet production requires a synchronous process of cell migration and proplatelet formation. ECM 4 and stromal cells 5 appear to play an important role in the inhibition of platelet production by MKs within the marrow microenvironment and the regulated loss of this specific interaction may precede MK migration from the bone marrow, and promote the onset of proplatelet formation.
The Wiskott Aldrich syndrome protein (WASp), which is exclusively expressed in hematopoietic cells, has emerged as a key signaling molecule 6 involved in cellular processes such as: i) reorganization of the actin cytoskeleton in response to specific signals, 7 ii) formation of podosomes, specialized actin-rich structures identified in motile primary cells such as macrophages, dendritic cells (DC) and osteoclasts 8 and iii) migration and cell trafficking of lymphocytes, DC, and granulocytes. 9 Accordingly, abnormalities of immune cell adhesion and migration observed in WAS, the X-linked primary immunodeficiency caused by mutations in the gene encoding WASp, have been partly ascribed to the lack of podosomes and concomitant cell migration defects in human and mouse models. In contrast, the pathophysiology of microthrombocytopenia, which is characteristic of WAS and its attenuated forms remains unclear, although it is considered that increased platelet peripheral destruction is the most important mechanism. 6 Indeed, splenectomy of WAS patients usually results in substantial (though sometimes incomplete) correction of thrombocytopenia, but persistence of small platelet size. 10 Isotope studies of platelet survival and release have also demonstrated that a component of the thrombocytopenia is related to inefficient platelet production. 11 This is unlikely to be due to a direct role of WASp in the process of pseudopod extension which leads to proplatelet formation because platelet production by human WAS MKs is normal in liquid culture in vitro. 12 In this system, platelet shedding occurs directly in the absence
For personal use only. on October 31, 2017. by guest www.bloodjournal.org From of cell-cell and cell-ECM interactions, and it is therefore limited in its ability to evaluate the important influences of MK interaction with the microenvironment and MK endothelial transmigration. WASp, an important regulator of the actin cytoskeleton, 7 may play an important role in these two last mechanisms. Mice generated by gene targeting have provided a powerful model to study the role of WASp in multiple cell lineages of the haematopoietic system. However, until now study of the mechanism of thrombocytopenia in WAS has been limited because unlike human patients, mice have only a moderate decrease in their platelet count and no abnormalities in their platelet size. 13 In spite of these species differences, we report here that proplatelet formation in WASp-deficient mice may occur ectopically within the bone marrow. We also show that WASp-deficient MKs have a defect in the negative regulation of proplatelet formation mediated by α2β1, one of the main receptors of fibrillar collagen I (CI), which is an important component of the bone marrow microenvironment. 14 In addition, in the presence of CI, WASp-deficient MKs show a profound defect in chemotactic migration which is consistent with marked cytoskeletal abnormalities, such as the lack of actin-rich podosome structures that were selectively induced by CI in wild type MKs.
Taken together, we suggest that WASp is involved in the modulation of MK actin reorganization and that this participates in the prevention of premature transmigration of immature MKs in response to chemotactic factors, and early platelet biogenesis in the bone marrow microenvironment. These events may provide a novel explanation to the defective platelet production in WASp-deficient mice and human patients.
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Materials and Methods

Animals and reagents
C57Bl/6 and wild type 129Sv/Ev mice were purchased from Iffa Credo (L'arbresle, France). WASp-deficient mice were provided by Drs Scott B. Snapper (Boston, MA), and Adrian Thrasher (London, UK). Mice were housed in animal facilities at the Institut Gustave Roussy (Villejuif, France) under specific pathogenfree conditions. CI (Horm) was purchased from Nycomed (Munich, Germany). Poly-L-lysine (PLL), fibronectine, anti-vinculin mAb and tetramethyl rhodamine isothiocyanate and GFOGER peptide were purified as described.
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Culture of MKs
Bone marrow (BM) nucleated cells from 129Sv, WASp-deficient mice or C57Bl/6 mice were obtained from femurs and tibiae of 6 to 8 weeks adult mice. The lineage-negative (lin -) fraction was purified from BM nucleated cells and grown for 72 hours in serum-free medium containing 10 ng/mL murine recombinant thrombopoietin (TPO) (R&D Systems, Oxon, UK) as previously described.
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Optical microscopy
Standard
Epon embedded thick sections (1µm) of wild type and WASp-deficient mouse bone marrow were stained with toluidine blue and examined by optical microscopy.
Immunohistochemistry
Immunohistochemistry was performed on paraffin embedded 4 µm tissue sections from the WASp and control femora previously fixed in 10% neutral-buffered formalin and embedded in paraffin. Standard indirect immunoperoxidase procedures were used. The primary antibody was a polyclonal rabbit antibody Factor VIII antihuman related antigen (dilution 1:2) (DAKO, Carpenteria, USA), an avidinbiotynylated peroxydase system was applied for the immunohistochemical stains.
Hematoxylin was the nuclear counterstain. Negative controls were performed by replacing the primary antibody with buffer.
Electronic microscopy
Samples were fixed in 1.5% glutaraldehyde for 1 hour and washed 3 times in 0.1 M phosphate buffer, pH 7.4. For morphologic examination, samples were postfixed in 1% osmic acid, dehydrated in ethanol, and embedded in Epon by standard methods. Samples were counterstained and were observed on a Philips CM 10 electron microscope (Eindhoven, The Netherlands).
Chemotactic assay
Cell migration was quantified through 12 µm-pore filters (Transwell™, 24-well cell clusters, VWR, Strasbourg, France). Serum-free medium (100 µl) containing 
Immunofluorescence analysis
CI (50 µg/mL), CVX (15 µg/mL), fibronectin (20 µg/mL), or fibrinogen (20 µg/mL) was incubated on coverslips overnight at 4°C. GFOGER peptide or PLL (20 µg/mL) was incubated 1 hour at room temperature (RT). Cells were seeded on precoated coverslips at 37°C for the indicated times and processed for labeling as described. 17 Briefly, cells were fixed in 2% paraformaldehyde for 10 minutes, washed with PBS, permeabilized using Triton X-100 (0.2%) for 3 minutes. They were then, 
Statistical analysis
The results are presented as mean ± SD. The data were analyzed using the 2-
Results
Platelet formation may occur inside the bone marrow of WASp-deficient mice
Microthrombocytopenia is a consistent feature of WAS and its mild form XLT. 6 However, in previous studies, we have not detected any obvious cytological alterations in primary human WASp-deficient MKs grown in vitro. 12 To investigate whether WASp might be involved in MK function under more physiological conditions, we analyzed bone marrow femurs of WASp-deficient mice and their normal counterparts 129Sv mice by conventional histology, immunohistochemistry, and electron microscopy.
In WASp-deficient bone marrow, MKs were more numerous compared to the normal mouse marrow as observed by conventional histology (data not shown).
Epon embedded sections of wild type bone marrow MKs (toluidine blue staining) showed centrally located nuclei ( Figure Proplatelets and platelets were also observed in WASp-deficient bone marrow either in clusters or scattered in the hematopoietic space (Table 1 and Figure 2 c) and these images were virtually absent from our control mice. Naked MK nuclei were also found in the WASp-deficient bone marrow space (Table 1 and Figure 2 d) again indicating that cytoplasmic shedding had occurred in situ. Naked nuclei were not observed in EM control marrow sections, suggesting that these are rare events in 129Sv mice marrow in contrast to Wasp-deficient mice marrow.
Loss of negative regulation of proplatelet formation by α2β1 integrin in WASpdeficient MKs
Recently, we showed that proplatelet formation of human MKs is inhibited by CI, the main component of ECM in the bone marrow. 4 We investigated whether adhesion to CI would affect proplatelet formation in wild type and WASp-deficient We previously demonstrated that CI mediates a very strong negative signal to proplatelet formation, and that a more discriminatory effect can be obtained by studying the response to ligation of the two main collagen receptors GPVI and α2β1
integrin. 4 Wild type and WASp-deficient MKs were thus plated on CVX 14 or GFOGER peptide, 15 two high affinity substrates for GPVI and α2β1 integrin, 
WASp-deficient MKs have a marked defect in migration in the presence of CI
WASp plays a crucial role in chemotactic migration and trafficking of several hematopoietic cell lineages. 9 It has also been suggested that immunodeficiency in WASp has been shown to be critical for podosome formation in other hematopoietic cell types in both human and murine models and has been found to localize to the core of podosomes in DC, macrophages and transformed fibroblasts. 
Discussion
Microthrombocytopenia is an invariable characteristic of WASp-deficient disease in humans. The mechanisms of thrombocytopenia are not fully understood, but are thought predominantly to be due to accelerated platelet destruction in the spleen associated with an intrinsic defect of platelet production. 6 WASp-deficient mice have only a moderate thrombocytopenia, which is not associated with reduced platelet size. 13 Although splenectomy has not been performed in these animals to evaluate the role of platelet destruction in the mechanism of thrombocytopenia, it is possible that a defect in platelet biogenesis may be an important mechanism. Our data support this hypothesis by showing that WASp deficiency affects platelet production by disturbing the negative regulation of proplatelet formation mediated by CI through α2β1, and MK migration induced by SDF-1 in the presence of CI.
Previously we have not observed significant cytological differences at the ultrastructural level between normal and WASp-deficient human MKs grown in vitro.
In addition proplatelet formation occurs normally in liquid culture in the presence of TPO. 12 As shown in this study, WASp-deficient murine MKs behaved similarly in vitro. However, in situ within the WASp-deficient mouse bone marrow, MKs were more numerous than in the controls, and were morphologically abnormal. This The chemokine SDF-1 has been shown to participate in the regulation of platelet formation especially in the absence of TPO. SDF-1 appears to play an important role in allowing the interaction of MKs with endothelial cells which regulate MK terminal differentiation. 19 In addition, SDF-1 controls the migration of hematopoietic cells and their retention in the bone marrow. 20 It has been previously shown that WASpdeficient T cells and CD34 + cells have an altered migration in response to SDF-1.
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In contrast, human WAS MKs derived in vitro from CD34 + cells have a normal migratory response to SDF-1 (unpublished results). We found a similar result for WASp-deficient murine MKs in the absence of ECM. In contrast, when transwells were coated with a complex ECM (matrigel) or CI to mimic a more physiological substratum, murine WASp-deficient MKs exhibited a marked defect in migration. The mechanism for defective migration under these conditions is not fully resolved, but these findings are reminiscent of abnormalities reported in other cell lineages including DC. 23 As for DC, we have demonstrated that primary wild type murine
MKs are able to assemble actin-rich classical podosomes structures, which interestingly were selectively induced by adhesion to CI, and by engagement of either GPVI or α2β1 receptors. Ventral localization of podosomes 8 and the condensation of vinculin 24 surrounding the actin core suggest that podosomes may play a role in the dynamics of cell adhesion. In contrast to DC, podosome assembly was temporally restricted to mature MKs (day 3 and 4 of culture), which may tie in with previous observations that differentiation of primary murine 25 and human 26 MKs is accompanied by an increase of GPVI expression and functional activation. In human platelets, WASp is selectively tyrosine-phosphorylated by CI, 27 likely through GPVI receptor. 28 The detailed role of α2β1integrin and GPVI in WASp activation and recruitment to podosomes remains to be investigated in murine MKs. However, as
shown for other WASp-deficient cell types, 8 we have demonstrated here that WASpdeficient MKs were completely devoid of podosome structures, further indicating that
WASp is a non-redundant regulator of podosome assembly in hematopoietic cells.
In accordance with our previous findings in primary human MKs, 4 we have found that CI inhibits proplatelet formation in murine MKs. Surprisingly, we also found that WASp participates in suppression of proplatelet formation in MKs adhering to CI through a mechanism involving engagement of α2β1 integrin.
Microtubule-based forces represent the main motor for proplatelet elongation, whereas a dynamic F-actin network is involved in the amplification and bifurcation of proplatelet ends to increase the yield of released platelets. For personal use only. on October 31, 2017. by guest www.bloodjournal.org From
